Palvella Therapeutics (PVLA) Consolidated Net Income (2013 - 2026)
Palvella Therapeutics' Consolidated Net Income came in at -$21.87 million for Q2 2026, compared with -$9.47 million a year earlier.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Consolidated Net Income (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Palvella Therapeutics reported Consolidated Net Income of -$61.7 million; for FY2025, it came in at -$41.72 million.
- Going back by year, Consolidated Net Income was -$17.43 million in FY2024, $18.69 million in FY2023, -$43.47 million in FY2022 and -$45.74 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Consolidated Net Income in data going back to Q2 2013.
- Business Quant data shows PVLA's Consolidated Net Income at -$15.77 million (Q1 2026), -$12.71 million (Q4 2025) and -$11.35 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Palvella Therapeutics | 2.47 Bn | 2.23 Bn | - | -24.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -24.68 Mn |
| Jun 30, 2026 | -21.88 Mn |
| Mar 31, 2026 | -15.76 Mn |
| Dec 31, 2025 | -12.74 Mn |
| Sep 30, 2025 | -11.13 Mn |
| Jun 30, 2025 | -9.58 Mn |
| Mar 31, 2025 | -8.19 Mn |
| Dec 31, 2024 | -3.37 Mn |
| Sep 30, 2024 | -6.97 Mn |
| Jun 30, 2024 | -4.37 Mn |
| Mar 31, 2024 | -2.73 Mn |
| Dec 31, 2023 | 37.96 Mn |
| Sep 30, 2023 | -10.95 Mn |
| Jun 30, 2023 | 4.27 Mn |
| Mar 31, 2023 | -13.36 Mn |
| Dec 31, 2022 | -8.88 Mn |
| Sep 30, 2022 | -9.84 Mn |
| Jun 30, 2022 | -10.67 Mn |
| Mar 31, 2022 | -4.98 Mn |
| Dec 31, 2021 | -9.32 Mn |
API Access
Palvella Therapeutics Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();